These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23573575)

  • 1. Devices to decrease stroke risk.
    Tuzcu EM
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):54S-58S. PubMed ID: 23573575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous patent foramen ovale and left atrial appendage closure.
    Versaci F; Saccà S; Mugnolo A; Pacchioni A; Reimers B
    J Cardiovasc Med (Hagerstown); 2012 Oct; 13(10):663-4. PubMed ID: 22011553
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent foramen ovale and cryptogenic stroke.
    Jaquis J
    Dimens Crit Care Nurs; 2007; 26(6):233-6. PubMed ID: 18090138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracardiac devices for stroke prevention.
    Nageh T; Meier B
    Prev Cardiol; 2006; 9(1):42-8. PubMed ID: 16407702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage occlusion through a patent foramen ovale: Should we or rather not?
    Tzikas A; Papadopoulos K; Konstantinou D; Ntaios G; Arampatzis C
    Hellenic J Cardiol; 2020; 61(6):442-443. PubMed ID: 32092394
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcatheter occlusion of the left atrial appendage for stroke prevention.
    Bayard YL; Ostermayer SH; Sievert H
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1003-8. PubMed ID: 16292991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
    Chiam PT; Ruiz CE
    J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 14. Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.
    Lip GY; Dagres N; Proclemer A; Svendsen JH; Pison L; Blomstrom-Lundqvist C;
    Europace; 2013 Jan; 15(1):141-3. PubMed ID: 23233491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device may reduce stroke risk from chronic atrial fibrillation.
    Mayo Clin Health Lett; 2006 Jan; 24(1):4. PubMed ID: 16468155
    [No Abstract]   [Full Text] [Related]  

  • 16. [Can strokes be prevented by cardiac catheterization procedures?].
    Ukkonen H; Lund J; Saraste A
    Duodecim; 2013; 129(3):295-301. PubMed ID: 23457778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of cryptogenic stroke or TIA in patients with patent foramen ovale successfully treated by using different kind of percutaneous occluder devices: five-year follow-up.
    de Cillis E; Acquaviva T; Basile DP; Cipriani F; Bortone AS
    Minerva Cardioangiol; 2010 Aug; 58(4):425-31. PubMed ID: 20938409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
    Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
    Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale and cryptogenic stroke in older patients.
    Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
    N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
    Eggers AE
    Med Hypotheses; 2006; 67(5):1072-5. PubMed ID: 16814938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.